CIAM
IMUX icon

Caitong International Asset Management’s Immunic IMUX Stock Holding History

Caitong International Asset Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31 Buy
+2
New +$25 ﹤0.01% 2435
2026
Q1 		– Hold
0
– – – 2377

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Caitong International Asset Management's IMUX Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Immunic (IMUX) in Q2 2026: 2 shares worth $31. The stake represents ﹤0.01% of the portfolio and ranks #2435 among its holdings.

55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Caitong International Asset Management held 2 shares of Immunic worth $31 as of Q2 2026.
  • Immunic was a new Caitong International Asset Management position in Q2 2026.
  • Immunic made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2435 holding.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.